Journal
TRANSFUSION
Volume 50, Issue 5, Pages 1144-1155Publisher
WILEY
DOI: 10.1111/j.1537-2995.2009.02551.x
Keywords
-
Categories
Funding
- Novartis
- The Institute for Patient Blood Management and Bloodless Medicine and Surgery at Englewood Hospital
- Medical Center
Ask authors/readers for more resources
Iron overload from chronic transfusion therapy can be extremely toxic. Excess transfusional iron is deposited in the liver, heart, and other organs as free iron, which can cause organ dysfunction and damage over time. Increased awareness of the risk of iron overload in patients requiring chronic transfusion therapy is needed, and such patients should be screened for hyperferritinemia. Those with serial serum ferritin levels exceeding 1000 ng/mL and a total infused red blood cell volume of 120 mL/kg of body weight or more should be treated with chelation therapy and then monitored to ensure that treatment adequately reduces iron levels.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available